Global Coalition on Aging and Novim Join Forces to Create The Alliance To Beat COVID-19 (ABC): A Partnership to Build the Trust and Confidence to Defeat our Global Pandemic

New York, New York (December 18, 2020) – The Global Coalition on Aging (GCOA), the world’s leading business voice on aging, and science-based communications firm Novim today announced our innovative partnership – Alliance to Beat COVID (ABC) – to advance the goals of COVID-19 immunization for all. As two leaders in science and health strategy, Novim and GCOA are joining forces in our ABC campaign for an effective communication and education strategy that will help global society build trust in COVID-19 vaccines so that everyone around the globe will be confident and motivated to “get vaccinated.”

“There are five essential steps for the COVID-19 vaccine to work effectively: First, do no harm, ensure it is safe. Second, make sure it’s effective. Third, create sufficient scaled manufacturing to produce enough vaccine for all. Fourth, power a distribution system to get the vaccines to us. And fifth, get us to actually take it,” said Michael Hodin, CEO, Global Coalition on Aging.  “Stunningly, it is the fifth that will prove the greatest barrier as we see COVID-19 vaccine reluctance skyrocketing across our planet.”

Trust in the science of COVID-19 vaccine innovation follows a paradoxically well-known path where medicines generally, vaccines in particular and adult vaccines even more, are too often unused. According to a recent World Health Organization report, information, an enabling environment, social influence, and motivation influence vaccine acceptance. We live in a world in which, as the Annals of Internal Medicine reports, all medicine compliance is under 50%. For adult vaccines, it’s even worse, with only 37% of American adults vaccinated against the flu. The WHO reports that in the EU, just 60% of adults have received commonly recommended vaccinations, and in Australia, only half of the over-65 population has been vaccinated for flu and pneumococcal pneumonia. Even in super-aging Japan, where prevention and healthy aging are priorities for the population overall and rates of vaccine-preventable diseases like pneumococcal pneumonia are high, there persists remarkably low compliance. Compounding the reluctance further is the growing antivax and vaccine skeptics movements and the politicization of the COVID-19 vaccine.

“For our part,” said Michael Ditmore, Executive Director of Novim, “we will put our expertise in science, research, and analysis to evaluate and communicate on complex, complicated global scientific issues to the challenge of our moment – communicating the necessity and benefits of global immunization to Covid-19.”

For more information on the Alliance to Beat COVID, and how you can help, go to https://alliancetobeatcovid.org.

About Novim

Novim was founded in January of 2008 at the Kavli Institute for Theoretical Physics, at UC Santa Barbara, California with a mission to assemble teams of scientists to render complex issues comprehensible to non-scientists. These projects and studies are short duration efforts on a wide variety of subjects, delivering reports and web and mobile applications that help explain subjects ranging from nuclear power to pension reform to climate change.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.